BIOLASE Technology, Inc. Establishes Company Offices in China and India
Published: Jun 06, 2011
IRVINE, CA--(Marketwire - June 06, 2011) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced the opening of its Asian headquarters, BIOLASE Technology Asia Pacific in Shanghai, China, and a direct sales and service office, BIOLASE Technology India Private Limited in Mumbai, India.
Sam Son, Vice President of Asia Pacific Operations, commented, "It has been a very busy five months establishing our direct presence in these two important emerging markets. We are already beginning to see results and an increased level of interaction with both private and government dental professionals that should result in significant increases in sales in the second half of 2011 and into 2012. Our distributors in Taiwan, Hong Kong, Japan, Korea and Thailand are also very appreciative of the additional clinical education and service support capabilities to the region."
BIOLASE Technology Asia Pacific is located in the vital Pudong business district and features a state-of-the-art clinical and laser service training facility and product showroom. A training session for the Chinese distribution network was already held May 21 in the new facility. The first doctor training event will take place June 18-19 followed by advanced service training for all of the dealers in the Asia Pacific region.
BIOLASE Technology India Private Limited, located in Mumbai, the business town of the country, is staffed with veteran dental industry sales, administrative and service staff with soon to be established training and showroom facilities that will support sales activities in Pakistan, Bangladesh, and Sri Lanka, as well as India.
Federico Pignatelli, Chairman and CEO, said, "China and India are large and vibrant emerging markets in Asia. These markets are not just huge markets, but thriving with growth and are now mature economies ready for adopting advanced dentistry and within that, laser dentistry. The first BIOLASE clinical education event in India was oversubscribed by more than 150 dentists. In our experience, doctors in China and India are high tech prone but much more likely to purchase high technology dental equipment from companies with a local presence for direct sales and support, together with the Company's support for clinical education and service in their market."
Pignatelli added, "We are also on track with our expansion plans in Latin America with an experienced manager on board since the first quarter of this year. We are currently evaluating and adding dealers and assessing various locations with the goal of establishing, in the months to come, the same level of operations as recently completed in China and India."
BIOLASE is headquartered in Irvine, California, and also maintains sales and support centers in Charlotte, North Carolina; Seoul, South Korea; Floss, Germany and Madrid, Spain.
About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.
This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.
For further information, please contact:
Allen & Caron